A Comparison of the Adverse Effects and Utility of Different Monoclonal Antibodies for SARS-CoV-2: A Retrospective Cohort Study

Introduction Multiple monoclonal antibody (mAb) treatments have been developed to combat the growing number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains. These treatments have been shown to be effective in reducing the risk of hospitalization and death from SARS-CoV-2 infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Knopp, Brandon W, Weiss, Hannah Z, Fahmy, Samer, Goldstein, Evan, Parmar, Jeniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482545/
https://www.ncbi.nlm.nih.gov/pubmed/37680398
http://dx.doi.org/10.7759/cureus.43094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482545/
https://www.ncbi.nlm.nih.gov/pubmed/37680398
http://dx.doi.org/10.7759/cureus.43094

Ejemplares similares